CASE STUDY | BGBx MEDICAL COMMUNICATIONS When Migraine Digital Presence Needed Credibility, We Engaged the Right DOLs. THE CHALLENGE Establishing the Right Relationships to Strengthen Digital Presence in...
CASE STUDY | PAYER COMMUNICATIONS When Orphan Disease Value Was Difficult to Demonstrate, We Built a Defensible Narrative. THE CHALLENGE Demonstrating Value in a Small, Complex Rare Disease...
CASE STUDY | PAYER COMMUNICATIONS When Pediatric Access Risked Delays, We Prepared the Market Ahead of Launch. THE CHALLENGE Expanding Access to a New Pediatric Population Without Delaying...
CASE STUDY | ADVERTISING When Rare Disease Diagnosis Was Missed, We Drove Recognition and Action. THE CHALLENGE Addressing Gaps in Recognition and Awareness in a Rare, Under-Recognized Disease...
CASE STUDY | ADVERTISING When HCP Engagement Was Fragmented, We Connected the Experience. THE CHALLENGE Fragmented Engagement in a Clinically Complex Treatment Landscape A leading pharmaceutical company sought...
CASE STUDY | ADVERTISING When Oncology Launch Required Immediate Impact, We Activated from Day One. THE CHALLENGE Launching in an Oncology Market Defined by Low Confidence and Competitive...
CASE STUDY | MEDICAL COMMUNICATIONS When Oncology Data Needed Direction, We Turned Insight into Action. THE CHALLENGE Translating New Oncology Data into Actionable Medical Strategy Following the availability...
CASE STUDY | PAYER COMMUNICATIONS When CNS Access Required More Than Value, We Reframed the Pathway. THE CHALLENGE Communicating Value Early in a Complex CNS Access Environment The...
CASE STUDY | MEDICAL COMMUNICATIONS When the Right Experts Were Unclear, We Defined the KOL Landscape. THE CHALLENGE Fragmented Care Models Complicated KOL Selection A pharmaceutical company preparing...
CASE STUDY | MEDICAL COMMUNICATIONS When Biomarker Testing Lacked Urgency, We Unified the Science. THE CHALLENGE Biomarker Testing and Awareness Increase Needed Prior to Launch A pharmaceutical company...